NewGenIvf Group Ltd (NIVF) FinancialsNIVFFinancialNewGenIvf Group Ltd

Evaluating the bottom line, NewGenIvf Group Ltd maintains a gross margin of 36.79%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -349.13%, while the net margin is -541.73%. These profitability ratios, combined with a Return on Equity (ROE) of 77.23%, provide a clear picture of how effectively NIVF converts its operational activities into shareholder value.

In the context of the broader market, NIVF competes directly with industry leaders such as IVF and TNON. With a market capitalization of $2.70M, it holds a significant position in the sector. When comparing efficiency, NIVF's gross margin of 36.79% stands against IVF's 28.37% and TNON's 68.53%. Such benchmarking helps identify whether NewGenIvf Group Ltd is trading at a premium or discount relative to its financial performance.

NIVF's financial performance shows volatility, with a net income of $16,823,355 in Q3 2025, but it turned negative again in Q4 2025 with a net loss of $7,668,922. The gross margin has also fluctuated significantly, dropping to 9.20% in Q3 2025 after being as high as 44.05% in Q3 2024.